Silverman S - Search Results

1

Primary non-adherence to bisphosphonates in an integrated healthcare setting.

Reynolds K, Muntner P, Cheetham TC, Harrison TN, Morisky DE, Silverman S, Gold DT, Vansomphone SS, Wei R, O'Malley CD. Reynolds K, et al. Among authors: silverman s. Osteoporos Int. 2013 Sep;24(9):2509-17. doi: 10.1007/s00198-013-2326-5. Epub 2013 Apr 18. Osteoporos Int. 2013. PMID: 23595561

2

Osteoporosis self-management: Choices For Better Bone Health.

Gold DT, Silverman SL. Gold DT, et al. South Med J. 2004 Jun;97(6):551-4. doi: 10.1097/00007611-200406000-00007. South Med J. 2004. PMID: 15255420

3

Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) study.

Miller PD, Silverman SL, Gold DT, Taylor KA, Chen P, Wagman RB. Miller PD, et al. Osteoporos Int. 2006 Jan;17(1):85-90. doi: 10.1007/s00198-005-1915-3. Epub 2005 Jun 25. Osteoporos Int. 2006. PMID: 15981021

4

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study.

Weiss TW, Gold DT, Silverman SL, McHorney CA. Weiss TW, et al. Curr Med Res Opin. 2006 May;22(5):949-60. doi: 10.1185/030079906X104740. Curr Med Res Opin. 2006. PMID: 16709316

5

Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?

Gold DT, Silverman SL. Gold DT, et al. Curr Osteoporos Rep. 2007 Mar;5(1):3-7. doi: 10.1007/BF02938616. Curr Osteoporos Rep. 2007. PMID: 17320021

6

Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis.

Cramer JA, Silverman SL, Gold DT. Cramer JA, et al. Curr Med Res Opin. 2007 Oct;23(10):2369-77. doi: 10.1185/030079907X226311. Curr Med Res Opin. 2007. PMID: 17711617

7

Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonate therapies.

Silverman SL, Gold DT, Cramer JA. Silverman SL, et al. South Med J. 2007 Dec;100(12):1214-8. doi: 10.1097/SMJ.0b013e31815a9685. South Med J. 2007. PMID: 18090964 Review.

8

Compliance and persistence with osteoporosis therapies.

Silverman SL, Gold DT. Silverman SL, et al. Curr Rheumatol Rep. 2008 Apr;10(2):118-22. doi: 10.1007/s11926-008-0021-x. Curr Rheumatol Rep. 2008. PMID: 18460266 Review.

9

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.

Cranney A, Wells GA, Yetisir E, Adami S, Cooper C, Delmas PD, Miller PD, Papapoulos S, Reginster JY, Sambrook PN, Silverman S, Siris E, Adachi JD. Cranney A, et al. Among authors: silverman s. Osteoporos Int. 2009 Feb;20(2):291-7. doi: 10.1007/s00198-008-0653-8. Epub 2008 Jul 29. Osteoporos Int. 2009. PMID: 18663402

10

Healthy users, healthy adherers, and healthy behaviors?

Silverman SL, Gold DT. Silverman SL, et al. J Bone Miner Res. 2011 Apr;26(4):681-2. doi: 10.1002/jbmr.384. J Bone Miner Res. 2011. PMID: 21433070 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,507 results

Search Page

Filters